1
|
Mookerji N, Mittal R, Hui A, Pfanner T, Broomfield S, Dean L, Adam B, Fung C, Tamm A, Kinnaird A. Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen-Positron Emission Tomography era. IJU Case Rep 2023; 6:337-340. [PMID: 37928279 PMCID: PMC10622191 DOI: 10.1002/iju5.12614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Accepted: 07/18/2023] [Indexed: 11/07/2023] Open
Abstract
Introduction The absence of prostate cancer on final surgical pathology after biopsy-proven prostate cancer is a rare finding. Case presentation Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound-guided biopsy in a man who underwent both magnetic resonance imaging and 18F-PSMA-1007 Positron Emission Tomography prior to radical prostatectomy. Conclusion pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.
Collapse
Affiliation(s)
- Nikhile Mookerji
- Division of Urology, Department of SurgeryUniversity of AlbertaEdmontonAlbertaCanada
| | - Rohan Mittal
- Department of PathologyUniversity of AlbertaEdmontonAlbertaCanada
| | - Amaris Hui
- Department of Radiology & Diagnostic ImagingUniversity of AlbertaEdmontonAlbertaCanada
| | - Tyler Pfanner
- Department of Radiology & Diagnostic ImagingUniversity of AlbertaEdmontonAlbertaCanada
| | - Stacey Broomfield
- Division of Urology, Department of SurgeryUniversity of AlbertaEdmontonAlbertaCanada
| | - Luke Dean
- Division of Urology, Department of SurgeryUniversity of AlbertaEdmontonAlbertaCanada
| | - Benjamin Adam
- Department of PathologyUniversity of AlbertaEdmontonAlbertaCanada
| | - Christopher Fung
- Department of Radiology & Diagnostic ImagingUniversity of AlbertaEdmontonAlbertaCanada
| | - Alexander Tamm
- Department of Radiology & Diagnostic ImagingUniversity of AlbertaEdmontonAlbertaCanada
| | - Adam Kinnaird
- Division of Urology, Department of SurgeryUniversity of AlbertaEdmontonAlbertaCanada
- Alberta Prostate Cancer Research Initiative (APCaRI)EdmontonAlbertaCanada
- Cancer Research Institute of Northern Alberta (CRINA)EdmontonAlbertaCanada
- Alberta Centre for Urologic Research and Excellence (ACURE)EdmontonAlbertaCanada
- Department of OncologyUniversity of AlbertaEdmontonAlbertaCanada
| |
Collapse
|
2
|
Arslan A, Alis D, Erdemli S, Seker ME, Zeybel G, Sirolu S, Kurtcan S, Karaarslan E. Does deep learning software improve the consistency and performance of radiologists with various levels of experience in assessing bi-parametric prostate MRI? Insights Imaging 2023; 14:48. [PMID: 36939953 PMCID: PMC10027972 DOI: 10.1186/s13244-023-01386-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Accepted: 02/04/2023] [Indexed: 03/21/2023] Open
Abstract
OBJECTIVE To investigate whether commercially available deep learning (DL) software improves the Prostate Imaging-Reporting and Data System (PI-RADS) scoring consistency on bi-parametric MRI among radiologists with various levels of experience; to assess whether the DL software improves the performance of the radiologists in identifying clinically significant prostate cancer (csPCa). METHODS We retrospectively enrolled consecutive men who underwent bi-parametric prostate MRI at a 3 T scanner due to suspicion of PCa. Four radiologists with 2, 3, 5, and > 20 years of experience evaluated the bi-parametric prostate MRI scans with and without the DL software. Whole-mount pathology or MRI/ultrasound fusion-guided biopsy was the reference. The area under the receiver operating curve (AUROC) was calculated for each radiologist with and without the DL software and compared using De Long's test. In addition, the inter-rater agreement was investigated using kappa statistics. RESULTS In all, 153 men with a mean age of 63.59 ± 7.56 years (range 53-80) were enrolled in the study. In the study sample, 45 men (29.80%) had clinically significant PCa. During the reading with the DL software, the radiologists changed their initial scores in 1/153 (0.65%), 2/153 (1.3%), 0/153 (0%), and 3/153 (1.9%) of the patients, yielding no significant increase in the AUROC (p > 0.05). Fleiss' kappa scores among the radiologists were 0.39 and 0.40 with and without the DL software (p = 0.56). CONCLUSIONS The commercially available DL software does not increase the consistency of the bi-parametric PI-RADS scoring or csPCa detection performance of radiologists with varying levels of experience.
Collapse
Affiliation(s)
- Aydan Arslan
- Department of Radiology, Umraniye Training and Research Hospital, Istanbul, Turkey
| | - Deniz Alis
- Department of Radiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
| | - Servet Erdemli
- Department of Radiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
| | - Mustafa Ege Seker
- School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
| | - Gokberk Zeybel
- School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
| | - Sabri Sirolu
- Department of Radiology, Istanbul Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | - Serpil Kurtcan
- Department of Radiology, Acibadem Healthcare Group, Istanbul, Turkey
| | - Ercan Karaarslan
- Department of Radiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
| |
Collapse
|
3
|
Otiono K, Nkonge B, Olaiya OR, Pierre S. Dépistage du cancer de la prostate chez les hommes noirs au Canada : Argument en faveur des soins stratifiés en fonction du risque. CMAJ 2023; 195:E101-E105. [PMID: 36649960 PMCID: PMC9851637 DOI: 10.1503/cmaj.220452-f] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Affiliation(s)
- Kikachukwu Otiono
- Faculté de médecine Michael G. DeGroote (Otiono), Exploration et commercialisation biomédicales (Nkonge) et Division de chirurgie plastique (Olaiya), Faculté des sciences de la santé, Université McMaster, Hamilton, Ont.; Division d'urologie (Pierre), Hôpital Queensway Carleton, Ottawa, Ont.
| | | | | | | |
Collapse
|
4
|
Otiono K, Nkonge B, Olaiya OR, Pierre S. Prostate cancer screening in Black men in Canada: a case for risk-stratified care. CMAJ 2022; 194:E1411-E1415. [PMID: 36280242 PMCID: PMC9616133 DOI: 10.1503/cmaj.220452] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Affiliation(s)
- Kikachukwu Otiono
- Michael G. DeGroote School of Medicine (Otiono), Biomedical Discovery and Commercialization (Nkonge) and Division of Plastic Surgery (Olaiya), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of Urology (Pierre), Queensway Carleton Hospital, Ottawa, Ont.
| | - Brenda Nkonge
- Michael G. DeGroote School of Medicine (Otiono), Biomedical Discovery and Commercialization (Nkonge) and Division of Plastic Surgery (Olaiya), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of Urology (Pierre), Queensway Carleton Hospital, Ottawa, Ont
| | - Oluwatobi R Olaiya
- Michael G. DeGroote School of Medicine (Otiono), Biomedical Discovery and Commercialization (Nkonge) and Division of Plastic Surgery (Olaiya), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of Urology (Pierre), Queensway Carleton Hospital, Ottawa, Ont
| | - Sean Pierre
- Michael G. DeGroote School of Medicine (Otiono), Biomedical Discovery and Commercialization (Nkonge) and Division of Plastic Surgery (Olaiya), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Division of Urology (Pierre), Queensway Carleton Hospital, Ottawa, Ont
| |
Collapse
|
5
|
Mason RJ, Marzouk K, Finelli A, Saad F, So AI, Violette PD, Breau RH, Rendon RA. UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes. Can Urol Assoc J 2022; 16:86-87. [PMID: 35358410 PMCID: PMC9054326 DOI: 10.5489/cuaj.7832] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Ross J. Mason
- Department of Urology, Dalhousie University, Halifax, NS, Canada
| | - Karim Marzouk
- Windsor General Hospital, Windsor, ON; and Western University, London, ON, Canada
| | - Antonio Finelli
- Division of Urology, University of Toronto, Toronto, ON, Canada
| | - Fred Saad
- Department of Surgery (Urology), University of Montreal, Montreal, QC, Canada
| | - Alan I. So
- Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
| | - Phillipe D. Violette
- Department of Surgery, Western University, London, ON, Canada
- Departments of Surgery and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
| | - Rodney H. Breau
- Division of Urology, University of Ottawa, Ottawa, ON, Canada
| | | |
Collapse
|
6
|
Mason RJ, Marzouk K, Finelli A, Saad F, So AI, Violette PD, Breau RH, Rendon RA. UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging. Can Urol Assoc J 2022; 16:E184-E196. [PMID: 35358414 PMCID: PMC9054332 DOI: 10.5489/cuaj.7851] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Ross J. Mason
- Department of Urology, Dalhousie University, Halifax, NS, Canada
| | - Karim Marzouk
- Windsor General Hospital, Windsor, ON; and Western University, London, ON, Canada
| | - Antonio Finelli
- Division of Urology, University of Toronto, Toronto, ON, Canada
| | - Fred Saad
- Department of Surgery (Urology), University of Montreal, Montreal, QC, Canada
| | - Alan I. So
- Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
| | - Philippe D. Violette
- Department of Surgery, Western University, London, ON, Canada
- Departments of Surgery and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
| | - Rodney H. Breau
- Division of Urology, University of Ottawa, Ottawa, ON, Canada
| | | |
Collapse
|